Charlie's Holdings, Inc.
- CHUC · OTC
- Medicinal Chemicals & Botanical Products
- Costa Mesa, CA
- 35 employees
- CIK 0001134765
Updated from SEC filings through
Top things to know
Executives
- Matthew P. Montesano Chief Financial Officer 4, 2026-09-04
- Henry Sicignano Iii President 4, 2026-09-04
-
Ryan Stump Chief Operating Officer 4, 2026-09-04
Charlie's Holdings, Inc. is a U.S. public company in medicinal chemicals & botanical products (SIC 2833), headquartered in Costa Mesa, CA. It trades as CHUC on OTC. Revenue was $20.9M in the fiscal year ending December 31, 2025, +169.4% from the year before. It reported about 35 employees.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $20.9M 10-K, 2026-04-01 | $7.8M 10-K, 2026-04-01 | $16.3M 10-K, 2024-04-15 | $26.4M 10-K, 2024-04-15 | $21.5M 10-K, 2023-04-17 |
| Operating income | -$2.2M 10-K, 2026-04-01 | -$3.3M 10-K, 2026-04-01 | -$2.2M 10-K, 2025-05-29 | -$1.8M 10-K, 2024-04-15 | $565K 10-K, 2023-04-17 |
| SG&A | $7.7M 10-K, 2026-04-01 | $6.2M 10-K, 2026-04-01 | $8.1M 10-K, 2025-05-29 | $11.0M 10-K, 2024-04-15 | $10.5M 10-K, 2023-04-17 |
| Net income | $4.5M 10-K, 2026-04-01 | -$4.2M 10-K, 2026-04-01 | -$2.1M 10-K, 2025-05-29 | -$1.6M 10-K, 2024-04-15 | $4.8M 10-K, 2023-04-17 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Matthew P. Montesano Chief Financial Officer at Charlie's Holdings Inc. (OTCQB:CHUC) | Chief Financial Officer | 4, 2026-09-04 |
| Henry Sicignano Iii | President | 4, 2026-09-04 |
| Ryan Stump | Chief Operating Officer | 4, 2026-09-04 |
| Edward Carmines | Director | 10-K, 2026-04-01 |
| Jeffrey Fox | Director | 10-K, 2026-04-01 |
| Michael King | Director | 10-K, 2026-04-01 |
| Scot Cohen | Director | 10-K, 2026-04-01 |
What Charlie's Holdings, Inc. does
Charlie's is a leader in the premium vapor products industry. Long known for its pioneering history and award-winning products, the Company’s mission is to provide adult smokers with better alternatives to combustible cigarettes. To this end, Charlie’s has developed a family of proprietary e-liquids as well as an array of compact, easy-to-use disposable vaping devices.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 280.6 million (as of August 17, 2026) | 10-Q, August 17, 2026 |
|---|---|---|
| Public float | $17.9M (as of June 30, 2025) | 10-K, April 1, 2026 |
| Reportable segments | 1 (period ending December 31, 2025) | 10-K, April 1, 2026 |
| Latest proxy statement | Meeting June 4, 2026 (filed April 20, 2026) | DEF 14A, April 20, 2026 |
| Auditor | Urish Popeck & Co., LLC (Pittsburgh, Pennsylvania) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| February 13, 2026 | Ryan Stump Chief Operating Officer | Buy | 250,000 | $50K | Form 4, February 13, 2026 |
| February 13, 2026 | Henry Sicignano Iii President | Buy | 250,000 | $50K | Form 4, February 13, 2026 |
| February 13, 2026 | Matthew P. Montesano Chief Financial Officer | Buy | 100,000 | $20K | Form 4, February 13, 2026 |
| February 13, 2026 | Michael D. King Director | Buy | 500,000 | $100K | Form 4, February 13, 2026 |
| February 13, 2026 | Edward Carmines Director | Buy | 250,000 | $50K | Form 4, February 13, 2026 |
| December 26, 2025 | Edward Carmines Director | Buy | 100,000 | $28K | Form 4, December 29, 2025 |
| December 17, 2025 | Henry Sicignano Iii President | Buy | 100,000 | $21K | Form 4, December 17, 2025 |
| September 9, 2025 | Edward Carmines Director | Buy | 44,723 | $13K | Form 4, September 9, 2025 |
Recent 8-K events
- 8-K filed 2026-08-04
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 7.01 Regulation FD disclosure
- 8-K filed 2026-06-05
- Item 5.02 Departure or appointment of directors or officers; compensation
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-05-21
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- 8-K filed 2026-02-13
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- 8-K filed 2025-08-11
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2025-06-03
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- 8-K filed 2025-04-17
- Item 1.01 Entry into a material definitive agreement
- Item 2.01 Completion of acquisition or disposition of assets
- 8-K filed 2024-11-27
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
- 8-K filed 2024-06-28
- Item 4.01 Changes in registrant's certifying accountant
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2024-06-03
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
Frequently asked questions about Charlie's Holdings, Inc.
- What does Charlie's Holdings, Inc. do?
- In its own words, from Item 1 of its 10-K: "Charlie's is a leader in the premium vapor products industry. Long known for its pioneering history and award-winning products, the Company’s mission is to provide adult smokers with better alternatives to combustible cigarettes. To this end, Charlie’s has developed a family of proprietary e-liquids as well as an array of compact, easy-to-use disposable vaping devices."
- What is Charlie's Holdings, Inc.'s revenue?
- $20.9M for the fiscal year ending December 31, 2025, from its 10-K filed April 1, 2026.
- Is Charlie's Holdings, Inc. profitable?
- Charlie's Holdings, Inc. reported net income of $4.5M for the fiscal year ending December 31, 2025.
- How many employees does Charlie's Holdings, Inc. have?
- About 35 as of December 31, 2025, as stated in its annual report.
- Who is the CFO of Charlie's Holdings, Inc.?
- Matthew P. Montesano, Chief Financial Officer, as named in a 4 filed September 4, 2026.
- Where is Charlie's Holdings, Inc. headquartered?
- Costa Mesa, CA.
- What is Charlie's Holdings, Inc.'s stock ticker?
- CHUC on OTC.
- What industry is Charlie's Holdings, Inc. in?
- Medicinal Chemicals & Botanical Products, SIC code 2833.
- What is Charlie's Holdings, Inc.'s website?
- charliesholdings.com. Investor relations: https://investors.charliesholdings.com.
- When does Charlie's Holdings, Inc. report earnings next?
- November 19, 2026. Source: estimate_10q_cadence.
- Is Charlie's Holdings, Inc. a public company?
- Yes. Charlie's Holdings, Inc. files with the SEC under CIK 0001134765 and trades as CHUC.
- Who audits Charlie's Holdings, Inc.?
- Urish Popeck & Co., LLC, Pittsburgh, Pennsylvania, as named in its latest annual report (10-K).
- How many shares of Charlie's Holdings, Inc. are outstanding?
- 280.6 million shares as of August 17, 2026, from its 10-Q filed August 17, 2026.
- What is Charlie's Holdings, Inc.'s public float?
- $17.9M as of June 30, 2025, as reported on the cover of its 10-K filed April 1, 2026.
- How many business segments does Charlie's Holdings, Inc. report?
- 1 reportable segment for the period ending December 31, 2025, from its 10-K filed April 1, 2026.
- When is Charlie's Holdings, Inc.'s annual shareholder meeting?
- June 4, 2026, per its proxy statement (DEF 14A) filed April 20, 2026.
- Have Charlie's Holdings, Inc. insiders traded stock recently?
- Since September 9, 2025, officers and directors reported 0 open-market sales and 8 purchases worth about $332K on Forms 4 and 5. The most recent: Ryan Stump (Chief Operating Officer) bought 250,000 shares on February 13, 2026.